- Report
- May 2024
- 137 Pages
Global
From €6236EUR$6,499USD£5,197GBP
- Report
- October 2024
- 199 Pages
Global
From €2399EUR$2,500USD£1,999GBP
- Report
- June 2024
- 200 Pages
Global
From €7628EUR$7,950USD£6,357GBP
- Report
- August 2024
- 139 Pages
Global
From €2878EUR$2,999USD£2,398GBP
- Report
- April 2024
- 124 Pages
Global
From €3790EUR$3,950USD£3,159GBP
- Report
- February 2024
- 182 Pages
Global
From €4318EUR$4,500USD£3,598GBP
- Report
- February 2024
- 132 Pages
Global
From €4558EUR$4,750USD£3,798GBP
- Report
- February 2024
- 180 Pages
Global
From €4768EUR$4,969USD£3,973GBP
- Report
- June 2022
- 250 Pages
Global
From €2399EUR$2,500USD£1,999GBP
- Book
- August 2024
North America
- Book
- June 2022
North America
- Book
- July 2019
North America

Hypothyroidism is a condition in which the thyroid gland does not produce enough of the thyroid hormone. Endocrinology is the medical specialty that deals with the diagnosis and treatment of disorders of the endocrine system, which includes the thyroid gland. Hypothyroidism is a common endocrine disorder, and its prevalence is increasing. Symptoms of hypothyroidism can include fatigue, weight gain, depression, dry skin, and constipation. Treatment for hypothyroidism typically involves taking a daily thyroid hormone replacement medication.
The hypothyroidism market is a subset of the larger endocrinology market. It is composed of pharmaceutical companies that develop and manufacture thyroid hormone replacement medications, as well as diagnostic companies that develop tests to diagnose hypothyroidism. Additionally, the market includes medical device companies that develop and manufacture devices used to monitor and treat hypothyroidism.
Some companies in the hypothyroidism market include AbbVie, Merck, Pfizer, Novartis, and Sanofi. Show Less Read more